SPEAKERS

NERCE 26 YEARS! SPEAKER BIOGRAPHIES

Northeast Region Conference 2012

Tuesday, April 10th Program:

Mass Spectrometry in the Clinical Laboratory

Thomas Annesley, Ph.D., is Professor of Clinical Chemistry at the University of Michigan. He obtained his Ph.D. from Rice University, followed by a post-doctoral fellowship at the Mayo Clinic. He joined the faculty at the University of Michigan in 1981. Dr. Annesley has been a member of the editorial boards of multiple journals, and is currently the Deputy Editor of the journal Clinical Chemistry. He is the author of the 14-part Clinical Chemistry Guide to Scientific Writing. Among the awards he has received are the Outstanding Speaker Award of the AACC and the award for Outstanding Contributions to Clinical Mass Spectrometry.

Adam S. Ptolemy, Ph.D., is the director of toxicology and Mass Spectrometry within the Department of Pathology at the Brigham and Women's Hospital and an Instructor in the Department of Pathology at Harvard Medical School, USA. He obtained his BSc in chemistry from Brock University, Canada in 2003 and a PhD in chemistry from McMaster University, Canada in 2008. He also completed a research fellowship in clinical chemistry at the children's Hospital Boston, Harvard Medical School, USA in 2010. His research interests focuses on the development of bioanalytical separation assays, clinical biomarker validation and toxicology.

Leslie M Shaw, Ph.D., Professor Director, Toxicology Laboratory Director, Biomarker Research Laboratory Department of Pathology & Laboratory Medicine Perelman School of Medicine University of Pennsylvania. I develop biomarker methods using multiplex immunoassay systems; and using HPLC/tandem mass spectrometry methods. The current focus of my studies are in two areas, the first is vitamin D-practical HPLC/tandem mass spectrometry methodology; the second in measurement of amyloid beta peptides in CSF as an index of Alzheimer's disease.

Point of Care Testing

Bruce Aiken, RALS Regional Business Manager - Northeast. Bruce is the Regional Busines Manager for RALS Data Management Systems covering the northeast area of the US. He has a wide range of diagnostic device and connectivity experience including time as an eastern regional sales manager for Response Biomedical, as well as hospital territory manager for International Technidyne Corporation (ITC). Most recently, Bruce had been a regional business consultant with Alere Home Monitoring.

Mike Kulpa, MBA. is Alere Account Executive Critical Care Group.

Steven M. Berkowitz, M.D. is Board certified in internal medicine, he is the Founder and President of SMB Health Consulting, specializing in assisting physicians and hospitals in improving clinical outcomes and performance. He has assisted over 150 clients in the USA and Canada.
Previously, for twelve years he was Chief Medical Officer for St. David's Healthcare, a six-hospital system in Austin, Texas, as well as the Division CMO for HCA Central and West Texas Division, which included 8 facilities in Austin and El Paso. As a member of the senior executive team, he had the overall responsibility of clinical outcomes improvement, physician development, strategic planning, and medical management for the Division. During this time he directed the implementation of numerous initiatives and programs to improve the system's clinical effectiveness. St. David's mortality index and CMS core measures are now among the best in the nation. STEMI times have reached national best practice levels, and SDH has been recognized at both the state and national levels for patient care quality and performance excellence. In 2008 St. David's received the Texas Award for Performance Excellence, a Baldrige-based award. He was also Chairman of Capital Area Providers, a 5.01-(a) Texas medical foundation with over 850 physicians. Prior to this position, Dr. Berkowitz had been National Practice Leader for Physician Services with the HayGroup. During this time he assisted over 75 major healthcare clients throughout the USA and Canada in the areas of strategic development, physician integration, physician compensation, and medical practice management. He was a senior executive for Harris Methodist Health System serving as Medical Director of the HMO and Chief Medical Officer for the integrated delivery system. He began his administrative career as Medical/Executive director for The Travelers in Phoenix, Arizona.

Susan Selgren, PhD is a Senior Marketing Manager with Siemens Healthcare Diagnostics in Norwood, MA. She has a Ph.D. in Physical Chemistry from the University of Notre Dame. Sue is currently responsible for worldwide marketing of Siemens urinalysis and diabetes products, both for Point of Care and Central Lab use. She works with core teams to understand customer needs as new products are developed. She enjoys traveling with her husband, and recent trips have included India, Hong Kong, Europe, and Australia.

Jo Ann Crain, BS, MLT (ASCP), Point of Care Specialist, Boston Medical Center. Boston, MA. MS Crain has been a POint of CAre Specialsist at BMC for 5 years. Previously, she was employed as a technolgist in the Hematology Laboratory at BMC.

Analytical Methods in the Chemistry Laboratory

Pieter Muntendam, M.D., joined BG Medicine, Inc. as President in November 2004 and was appointed as Chief Executive Officer in December 2005. He also has served as a member of the board of directors since November 2004. He is a biopharmaceutical and healthcare executive with over 20 years of business experience ranging from early stage enterprises to multinational corporations. Dr. Muntendam joined BG Medicine, Inc. from NetNumina Solutions, Inc., a professional services company, where he served as Director of the Biopharma Healthcare Practice from April 2003 to October 2004. Prior to joining NetNumina, he co-founded Vitivity Inc., a subsidiary of Millennium Pharmaceuticals, Inc., and served as Vice President, Medicine from July 2001 to April 2003. He founded the health management firm ProMedex Inc. in 1996, where he served as President and Chief Executive Officer and chairman of the board until ProMedex was acquired by Landacorp, Inc. in 2001. Prior to that, he served as Vice President of Care Management at Glaxo Wellcome (now GlaxoSmithKline plc), where he was responsible for the development and implementation of its entry strategy within the field of care and disease management. Dr. Muntendam began his career with Organon International Inc. in December of 1982, after which he was appointed Vice President of Research and Development, International at Johnson & Johnson, and appointed as a member of the boards of directors for two Johnson & Johnson operating companies. Dr. Muntendam received his M.D. from Leiden University in the Netherlands.

Laura Worfolk is Scientific Director of Coagulation for Quest Diagnostics. Previously she was the Scientific Manager for Diagnostica Stago, a manufacturer of equipment and reagents for coagulation testing. Her undergraduate degree was in Medical Technology and graduate school degree in Cell Biology. Her entire career has been in hemostasis and thrombosis, either in clinical laboratories or in the diagnostic industry.

Richard M. O'Hara, Jr., Ph.D. received his doctoral degree in Immunology from The University of Texas Southwestern Medical School in Dallas, Texas. Following that he received postdoctoral training at the Harvard Medical School, where he worked on mechanisms of T cell mediated suppression. In 1988 he took a position at Genetics Institute (later Wyeth Research) in Cambridge, MA. His work on cytokine biology led to the development of two new therapeutic entities in hematology and oncology. Later work in the role of costimulation in graft rejection and autoimmunity led to the development of several other drug candidates. He joined The Binding Site in 2007 as Senior Technical Director, focusing on the Freelite assay for serum light chains. Dr. O'Hara is the author of numerous scientific publications and holds several US patents related to his work in autoimmunity and transplantation.

Phlebotomy

Sol F. Green, Ph.D., FACB, has over 25 years clinical research experience in fields of Laboratory Medicine, including preanalytical variability and errors, clinical chemistry and automation, blood pH and gases, endocrinology, therapeutic drug monitoring, toxicology, special chemistry and cardiac markers. He is a fellow of the National Academy of Clinical Biochemistry, and is a certificated Clinical Laboratory Director. Over the past seven years, he has been responsible for oversight of the BD Diagnostics Preanalytical Systems Department of Medical Affairs in North America, Latin America, Europe, the Middle East and Africa. He has leadership experience in professional organizations relevant to clinical practices and standards: Global Preanalytical Scientific Committee member, International Federation of Clinical Chemistry and Laboratory Medicine - Corporate member, Association of Clinical Scientist - Scientific Council, Clinical Laboratory and Analytical Sciences - Section Executive Committee and Past Chair, American Association of Clinical Chemistry -

Becky Socha MS, MLS(ASCP)CM , received her undergraduate degree in Medical Technology from Merrimack College in N Andover, Ma and her MS in Clinical Laboratory Science from UMass Lowell. Becky is currently the laboratory shift supervisor at Parkland Medical Center where she has worked for 14 years. She also teaches as adjunct faculty in the Health Sciences department at Merrimack College in N Andover, Ma. and is adjunct faculty in the Clinical Laboratory Science department at the University of Massachusetts, Lowell campus. Becky is a trained "Labs are Vital" advocate and speaker. She has always loved learning and teaching and is an advocate of continuing education.

Management

Sean Hand, BS, Vice President of Ancillary Services Hallmark Health SystemGraduated in 1988 with a bachelor's degree from the University of Pittsburgh in Health Information Management. Worked as Director of HIM in both tertiary and community hospitals variety of leaderships positions within

Kris Mailepars, MBA, is a New England native with 13 years experience in Training and Leadership Development (Consumer Goods, Finance & Consulting). Kris earned his MBA fro the University of Otago in New Zealand in 2010, his thesis work was on Generational Differences. He is currently head of Organizational Development and Training at Catholic Medical Center and serves on the board of the NH Chapter of American Society of Training and Development.

David Jackson, MBA is the Senior Vice President of Strategic Services at ARUP Laboratories. He has been with ARUP since 2000 and holds BA and MBA degrees from the University of Utah. Mr. Jackson's specific areas of responsibility at ARUP include strategic planning, project management, education, human services, ARUP's Family Health Clinic, and health and wellness programs. He has also directed facility operations and development, and new building construction during his tenure at ARUP.

EVENING DINNER AND LECTURE